SALARIUS PHARMACEUTICALS INC (SLRX) Stock Income Statement
NASDAQ:SLRX - Nasdaq - US79400X4043 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.84M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 5.68M | 5.73M | 12.89M | 22.98M | 14.65M | |||
| Research and Development | 602.50K | 770.00K | 7.17M | 15.84M | 8.55M | |||
| Selling, General, and Administrative Expenses | 5.08M | 4.96M | 5.72M | 7.14M | 6.10M | |||
| Operating Income | -5.68M | -5.73M | -12.89M | -22.98M | -12.81M | |||
| Interest Income/Expense | 111.50K | 158.50K | 352.30K | 233.20K | 44.70K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | -8.87M | N/A | |||
| Income Before Taxes | -5.57M | -5.58M | -12.54M | -31.61M | -12.77M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -5.57M | -5.58M | -12.54M | -31.61M | -12.77M | |||
| EBITDA | -5.68M | -5.73M | -12.88M | -22.97M | -12.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.17 | -5.79 | -30.74 | -119.02 | -61.73 | |||
| Non GAAP EPS | N/A | N/A | N/A | -86.40 | -60.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | -693.85% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -696.28% | |||
All data in USD